Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 31 (RPL21P31)
- Target
- RPL21P31
- Molecular classification
- Other (Pseudogene)
01
Overview
Ribosomal protein L21 pseudogene 31 (RPL21P31) is a non-protein-coding pseudogene related to the ribosomal protein L21 gene. Pseudogenes are genomic DNA sequences similar to known genes but are nonfunctional typically due to mutations or lack of regulatory elements required for expression. RPL21P31 does not encode a functional protein and is not known to participate directly in cellular processes or disease mechanisms. The presence of multiple RPL21 pseudogenes throughout the genome is a common feature of ribosomal protein genes, whose functional counterparts are essential components of the ribosome's large (60S) subunit involved in protein synthesis.
- Other names
- RPL21_12_296RPL21P31Ribosomal protein L21 pseudogene 31
02
Mechanism of action
None. There are no mechanisms of action for drugs targeting this pseudogene
03
Biological functions
Other (No protein product; typical pseudogenes do not have established biological functions apart from possible roles in gene regulation or genomic structure)
04
Disease associations
Other (No direct association with disease. Note: Mutations in the *functional* RPL21 gene, not the pseudogene, can cause Hypotrichosis simplex of the scalp)
Beyond the preview
Go deeper on Ribosomal protein L21 pseudogene 31 (RPL21P31).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 31 (RPL21P31).